早期非小细胞肺癌患者行电视辅助胸腔镜手术的有利结局:一项倾向性评分匹配分析
这项回顾性队列研究纳入2007至2015年间接受手术切除的982例I-IIA期非小细胞肺癌患者,经倾向性评分匹配比较开胸组与电视辅助胸腔镜手术(VATS)组各225例。VATS组总生存期显著更优(P=0.042),5年生存率61% vs 78%(P=0.0081),术后肺不张和输血需求更少,术后住院时间更短。
要点
- VATS组5年生存率78% vs 开胸组61%(P=0.0081),总生存期显著获益(P=0.042)。
- VATS组术后肺不张4% vs 开胸组10%(P=0.0052),输血需求4% vs 12%(P=0.0054)。
- VATS组术后住院时间平均7.25天 vs 开胸组9.34天(P<0.0001)。
核心结论
- 早期非小细胞肺癌患者行VATS手术较开胸手术并发症更少、术后住院时间更短且总生存期更优。
研究设计与样本
- 回顾性队列研究,分析2007至2015年间接受手术切除的982例I-IIA期非小细胞肺癌患者。
- 采用倾向性评分匹配比较开胸组225例与VATS组225例,匹配变量包括pTNM、性别、Charlson合并症指数、切除类型和组织学诊断。
主要发现
- VATS组总生存期显著优于开胸组(P=0.042);3年生存率两组无显著差异(P=0.14),5年生存率VATS组78% vs 开胸组61%(P=0.0081)。
- 校正pTNM、性别和年龄后,VATS相关风险比HR 0.63(95%CI 0.40-0.98)。
- VATS组术后肺不张发生率4% vs 开胸组10%(P=0.0052),输血需求4% vs 12%(P=0.0054)。
- VATS组术后住院时间平均7.25天 vs 开胸组9.34天(P<0.0001)。
- 30天死亡率VATS组1% vs 开胸组1%(P=0.66),90天死亡率VATS组1% vs 开胸组1%(P=0.48),均无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The video-assisted thoracoscopic surgery (VATS) approach has become a standard for the treatment of early-stage non-small-cell lung cancer (NSCLC). Recently published meta-analyses proved the benefit of VATS versus thoracotomy for overall survival (OS) and reduction of postoperative complications. The aim of this study was to compare early outcomes, long-term survival and rate of postoperative complications of the VATS approach versus thoracotomy. METHODS: In this retrospective cohort study, we analysed 982 individuals who underwent surgical resection for Stage I-IIA NSCLC between 2007 and 2015. Thirty- and 90-day mortality rates, length of hospital stay, rate of complications and OS were assessed. Propensity score matching was performed to compare 2 groups of patients. Two hundred and twenty-five individuals from the thoracotomy group and 225 patients from the VATS group were matched regarding pTNM, sex, the Charlson comorbidity index, type of resection and histological diagnosis. RESULTS: In the propensity score-matched patient group, the VATS approach was associated with a significant benefit regarding OS (P = 0.042). Although no significant difference was observed (P = 0.14) in the 3-year survival rate of patients who had a thoracotomy versus VATS, the 5-year survival rate among patients with VATS increased significantly (61% vs 78%, P = 0.0081). The adjusted VATS-related hazard ratio for pTNM, sex and age was 0.63 (95% confidence interval 0.40-0.98). The VATS surgical approach also reduced both the rate of postoperative atelectasis (4% for VATS vs 10% for open thoracotomy; P = 0.0052) and the need for blood transfusions (4% vs 12% respectively, P = 0.0054) and significantly shortened the postoperative length of stay (mean 7.25 vs 9.34 days, P < 0.0001). No significant differences in the 30-day mortality (1% vs 1%, P = 0.66) and 90-day mortality (1% vs 1%, P = 0.48) rates were observed. CONCLUSIONS: Patients with early-stage NSCLC operated on with VATS had fewer complications, shorter postoperative length of stay and better OS compared to those who were operated on by thoracotomy.
引用
- Dziedzic R, Marjanski T, Binczyk F, et al. Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2018. PMID: 29547899. doi:10.1093/ejcts/ezy101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。